查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1945292

2026年全球基因检测市场报告

Hereditary Genetic Testing Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，基因检测市场发展迅速，预计将从2025年的238.8亿美元成长到2026年的265.6亿美元，复合年增长率达11.2%。这一增长归因于多种因素，例如遗传疾病盛行率的上升、分子诊断在临床上的应用日益广泛、诊断检查室的扩张、人们对遗传疾病认识的提高以及基础基因检测技术的广泛应用。

预计未来几年基因检测市场将快速成长，到2030年市场规模将达到401.2亿美元，复合年增长率（CAGR）为10.9%。预测期内的成长要素包括：次世代定序技术的进步、个人化医疗需求的成长、药物基因组学应用的拓展、预防性医疗医疗费用支出的增加以及基因咨询服务的普及。预测期内的主要趋势包括：预防性和预测性基因检测的普及率不断提高、对早期癌症风险评估的需求不断增长、面向消费者的基因检测服务日益增长、产前和新生儿基因筛检的扩展以及人们对遗传性心血管疾病和罕见疾病的认识不断提高。

癌症发生率的不断上升将进一步推动未来基因检测市场的扩张。癌症是一组以细胞不受控制地生长为特征的疾病，并有可能侵入或转移到身体的其他部位。癌症发生率的上升受多种因素影响，例如年龄增长、生活方式改变、环境暴露、遗传易感性以及诊断技术的进步。基因检测有助于识别与癌症风险增加相关的遗传基因突变，从而实现早期监测和预防策略。例如，根据英国麦克米伦癌症援助组织（Macmillan Cancer Support）统计，截至2024年8月，英国有超过300万人患有癌症，预计到2025年这一数字将增至350万，到2030年将增至400万，到2040年将增至530万。因此，日益加重的癌症负担正在推动基因检测市场的扩张。

基因检测市场的主要企业正致力于开发先进的基因组解决方案，例如多癌多基因检测，以支援早期检测和个人化治疗策略。多癌多基因检测可同时分析多个基因，识别与不同癌症相关的突变，从而支持风险评估和个人化治疗。例如，总部位于美国的癌症筛检和诊断检测服务提供者Exact Sciences于2024年2月推出了Riskguard遗传性癌症检测。该检测使用血液或唾液样本，可提供基因特异性和遗传性癌症风险的个人化讯息，从而支持知情的筛检决策、治疗计划和家族风险评估。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球基因检测市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 人工智慧（AI）和自主人工智慧
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 物联网、智慧基础设施和互联生态系统
  • 主要趋势
    • 扩大预防性和预测性基因检测的应用
    • 对早期癌症风险评估的需求日益增长
    • 直接面向消费者的基因检测服务的成长
    • 扩大产前和新生儿基因筛检
    • 提高对遗传性心血管疾病和罕见疾病的认识

第五章 终端用户产业市场分析

  • 医院和诊所
  • 诊断检查室
  • 研究所
  • 直接面向消费者的基因检测公司（DTC）
  • 遗传咨询中心

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球基因检测市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球基因检测市场规模、对比及成长率分析
  • 全球基因检测市场表现：规模与成长，2020-2025年
  • 全球基因检测市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 按类型
  • 预测性/无症状检测、基因带原检测、产前/新生儿检测、诊断性检测、药物基因体学检测及其他类型
  • 透过技术
  • 细胞遗传学、生物化学和分子检测
  • 透过临床应用
  • 癌症基因检测、心血管基因检测、神经系统基因检测、罕见疾病基因检测
  • 最终用户
  • 医院/诊所、诊断实验室、研究实验室、直接面向消费者（DTC）的基因检测公司
  • 按类型细分：预测性测试和临床前测试
  • 基因检测用于疾病风险预测、遗传性癌症风险检测、心血管疾病风险检测、神经退化性疾病风险检测
  • 按类型细分：基因带原检测
  • 遗传疾病检测、体染色体隐性遗传疾病基因筛检、遗传疾病带因者状态检测
  • 按类型细分：产前和新生儿检测
  • 非侵入性产前检测（NIPT）、羊膜穿刺术及绒毛膜取样（CVS）、新生儿筛检、孕前基因筛检
  • 按类型细分：诊断测试
  • 基因检测用于确诊疑似遗传疾病、检测遗传症候群和先天性疾病、诊断癌症和肿瘤谱分析。
  • 按类型细分：药物基因组学检测
  • 药物反应和疗效的基因检测、药物敏感性和副作用检测、个人化医疗和治疗优化
  • 按类型细分：其他类型
  • 用于健康促进和生活方式的基因检测、用于祖源和家族史研究的基因检测、用于研究目的的基因检测

第十章 区域与国家分析

  • 全球基因检测市场：依地区、绩效及预测划分，2020-2025年、2025-2030年预测、2035年预测
  • 全球基因检测市场：依国家、绩效及预测划分，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第三十六章：竞争格局与公司概况

  • 基因检测市场：竞争格局及市场占有率（2024年）
  • 基因检测市场：公司估值矩阵
  • 基因检测市场：公司概况
    • F. Hoffmann-La Roche Ltd.
    • Abbott Laboratories
    • Laboratory Corporation of America Holdings
    • Quest Diagnostics Incorporated
    • Eurofins Scientific SE

第37章：其他领先和创新企业

  • Hologic Inc., Exact Sciences Corporation, Fulgent Genetics Inc., BioReference Laboratories Inc., BGI Group, Invitae Corporation, Color Health Inc., MedGenome Inc., Devyser AB, Mapmygenome India Ltd., Igenomix SLP, Myriad Genetics Inc., Natera Inc., Ambry Genetics Corporation, GeneDx LLC

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年基因检测市场：提供新机会的国家
  • 2030年基因检测市场：蕴藏新机会的细分领域
  • 2030年基因检测市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME5MHGTE01_G26Q1

Hereditary genetic testing analyzes DNA to detect inherited gene mutations that may increase the risk of disease. It helps identify genetic conditions that may be passed from parents to children, including cancers, heart diseases, and rare inherited disorders.

The primary types of hereditary genetic testing include predictive and presymptomatic testing, carrier testing, prenatal and newborn testing, diagnostic testing, pharmacogenomic testing, and others. Predictive and presymptomatic testing helps identify individuals with a genetic likelihood of developing specific diseases before clinical symptoms appear. The technologies used include cytogenetic testing, biochemical testing, and molecular testing. Clinical applications include cancer genetic testing, cardiovascular genetic testing, neurological genetic testing, and rare disease genetic testing. The end users consist of hospitals and clinics, diagnostic laboratories, research institutes, and direct-to-consumer (DTC) genetic testing providers.

Tariffs are impacting the hereditary genetic testing market by increasing costs for imported laboratory instruments, reagents, and sequencing equipment, impacting overall testing affordability. Molecular testing and pharmacogenomic testing segments are most affected, particularly in regions such as Asia-Pacific and Latin America that rely heavily on imported diagnostic technologies. These cost pressures have slowed adoption in price-sensitive markets. However, tariffs have also encouraged domestic manufacturing of testing kits and reagents, fostering local innovation and strengthening regional diagnostic capabilities.

The hereditary genetic testing market research report is one of a series of new reports from The Business Research Company that provides hereditary genetic testing market statistics, including hereditary genetic testing industry global market size, regional shares, competitors with a hereditary genetic testing market share, detailed hereditary genetic testing market segments, market trends and opportunities, and any further data you may need to thrive in the hereditary genetic testing industry. This hereditary genetic testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hereditary genetic testing market size has grown rapidly in recent years. It will grow from $23.88 billion in 2025 to $26.56 billion in 2026 at a compound annual growth rate (CAGR) of 11.2%. The growth in the historic period can be attributed to increasing prevalence of hereditary disorders, growing clinical adoption of molecular diagnostics, expansion of diagnostic laboratories, rising awareness of genetic diseases, availability of basic genetic testing technologies.

The hereditary genetic testing market size is expected to see rapid growth in the next few years. It will grow to $40.12 billion in 2030 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to advancements in next-generation sequencing technologies, growing demand for personalized medicine, expansion of pharmacogenomic applications, increasing healthcare spending on preventive care, wider integration of genetic counseling services. Major trends in the forecast period include rising adoption of preventive and predictive genetic testing, increasing demand for early cancer risk assessment, growth of direct-to-consumer genetic testing services, expansion of prenatal and newborn genetic screening, rising awareness of inherited cardiovascular and rare diseases.

The increasing prevalence of cancer is increasingly supporting the expansion of the hereditary genetic testing market going forward. Cancer refers to a group of diseases characterized by uncontrolled cell growth with the potential to invade or spread to other parts of the body. The growing prevalence of cancer is influenced by aging populations, lifestyle changes, environmental exposures, genetic predispositions, and improved diagnostic capabilities. Hereditary genetic testing helps identify inherited genetic mutations linked to increased cancer risk, enabling early surveillance and preventive strategies. For example, in August 2024, according to Macmillan Cancer Support, a UK-based organization, more than 3 million people in the UK were living with cancer in 2024, with projections indicating growth to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. As a result, the increasing cancer burden is contributing to the expansion of the hereditary genetic testing market.

Leading companies operating in the hereditary genetic testing market are focusing on developing advanced genomic solutions, such as multi-cancer multigene panels, to support early detection and personalized treatment strategies. Multi-cancer multigene panels analyze multiple genes simultaneously to identify mutations linked to different cancers, aiding risk assessment and tailored care. For example, in February 2024, Exact Sciences Corporation, a US-based provider of cancer screening and diagnostic tests, launched the Riskguard hereditary cancer test. This test delivers personalized insights into gene-specific and familial cancer risks using a blood or saliva sample, supporting informed screening decisions, treatment planning, and family risk evaluation.

In August 2024, Laboratory Corporation of America Holdings (Labcorp), a US-based laboratory services company, acquired selected assets of Invitae Corporation for an undisclosed amount. With this acquisition, Labcorp aims to expand its specialty testing capabilities and strengthen its use of genetic data to improve clinical trials and treatment approaches in oncology and select rare diseases. Invitae Corporation is a US-based provider of medical genetics services, including genetic testing solutions for oncology and rare diseases.

Major companies operating in the hereditary genetic testing market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Hologic Inc., Exact Sciences Corporation, Fulgent Genetics Inc., BioReference Laboratories Inc., BGI Group, Invitae Corporation, Color Health Inc., MedGenome Inc., Devyser AB, Mapmygenome India Ltd., Igenomix S.L.P., Myriad Genetics Inc., Natera Inc., Ambry Genetics Corporation, GeneDx LLC, Centogene N.V., CooperSurgical Inc., Sema4

North America was the largest region in the hereditary genetic testing market in 2025 and it is expected to be the fastest-growing region in the forecast period. The regions covered in the hereditary genetic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the hereditary genetic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The hereditary genetic testing market includes revenues earned by entities by providing services such as carrier screening, prenatal testing, and newborn screening. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hereditary Genetic Testing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses hereditary genetic testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hereditary genetic testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hereditary genetic testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Predictive And Presymptomatic Testing; Carrier Testing; Prenatal And Newborn Testing; Diagnostic Testing; Pharmacogenomic Testing; Other Types
  • 2) By Technology: Cytogenetic Testing; Biochemical Testing; Molecular Testing
  • 3) By Clinical Application: Cancer Genetic Testing; Cardiovascular Genetic Testing; Neurological Genetic Testing; Rare Diseases Genetic Testing
  • 4) By End User: Hospitals And Clinics; Diagnostic Laboratories; Research Institutes; Direct To Consumer (DTC) Genetic Testing Companies
  • Subsegments:
  • 1) By Predictive And Presymptomatic Testing: Genetic Testing For Disease Risk Prediction; Testing For Inherited Cancer Risks; Cardiovascular Disease Risk Testing; Neurodegenerative Disease Risk Testing
  • 2) By Carrier Testing: Testing For Inherited Genetic Disorders; Genetic Screening For Autosomal Recessive Diseases; Testing For Carrier Status Of Inherited Conditions
  • 3) By Prenatal and Newborn Testing: Non-Invasive Prenatal Testing (NIPT); Amniocentesis and Chorionic Villus Sampling (CVS); Newborn Screening For Genetic Disorders; Preconception Genetic Screening
  • 4) By Diagnostic Testing: Genetic Testing For Confirming Suspected Genetic Disorders; Testing For Inherited Syndromes And Congenital Diseases; Diagnostic Testing For Cancer And Tumor Profiling
  • 5) By Pharmacogenomic Testing: Genetic Testing For Drug Response And Efficacy; Testing For Drug Sensitivities And Side Effects; Personalized Medicine And Treatment Optimization
  • 6) By Other Types: Genetic Testing For Wellness And Lifestyle; Genetic Testing For Ancestry And Genealogy; Research-Oriented Genetic Testing
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Abbott Laboratories; Laboratory Corporation of America Holdings; Quest Diagnostics Incorporated; Eurofins Scientific SE; Hologic Inc.; Exact Sciences Corporation; Fulgent Genetics Inc.; BioReference Laboratories Inc.; BGI Group; Invitae Corporation; Color Health Inc.; MedGenome Inc.; Devyser AB; Mapmygenome India Ltd.; Igenomix S.L.P.; Myriad Genetics Inc.; Natera Inc.; Ambry Genetics Corporation; GeneDx LLC; Centogene N.V.; CooperSurgical Inc.; Sema4
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Hereditary Genetic Testing Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Hereditary Genetic Testing Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Hereditary Genetic Testing Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Hereditary Genetic Testing Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Rising Adoption Of Preventive And Predictive Genetic Testing
    • 4.2.2 Increasing Demand For Early Cancer Risk Assessment
    • 4.2.3 Growth Of Direct-To-Consumer Genetic Testing Services
    • 4.2.4 Expansion Of Prenatal And Newborn Genetic Screening
    • 4.2.5 Rising Awareness Of Inherited Cardiovascular And Rare Diseases

5. Hereditary Genetic Testing Market Analysis Of End Use Industries

  • 5.1 Hospitals And Clinics
  • 5.2 Diagnostic Laboratories
  • 5.3 Research Institutes
  • 5.4 Direct To Consumer (Dtc) Genetic Testing Companies
  • 5.5 Genetic Counseling Centers

6. Hereditary Genetic Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Hereditary Genetic Testing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Hereditary Genetic Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Hereditary Genetic Testing Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Hereditary Genetic Testing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Hereditary Genetic Testing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Hereditary Genetic Testing Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Hereditary Genetic Testing Market Segmentation

  • 9.1. Global Hereditary Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Predictive And Presymptomatic Testing, Carrier Testing, Prenatal And Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, Other Types
  • 9.2. Global Hereditary Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cytogenetic Testing, Biochemical Testing, Molecular Testing
  • 9.3. Global Hereditary Genetic Testing Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cancer Genetic Testing, Cardiovascular Genetic Testing, Neurological Genetic Testing, Rare Diseases Genetic Testing
  • 9.4. Global Hereditary Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Direct To Consumer (DTC) Genetic Testing Companies
  • 9.5. Global Hereditary Genetic Testing Market, Sub-Segmentation Of Predictive And Presymptomatic Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Genetic Testing For Disease Risk Prediction, Testing For Inherited Cancer Risks, Cardiovascular Disease Risk Testing, Neurodegenerative Disease Risk Testing
  • 9.6. Global Hereditary Genetic Testing Market, Sub-Segmentation Of Carrier Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Testing For Inherited Genetic Disorders, Genetic Screening For Autosomal Recessive Diseases, Testing For Carrier Status Of Inherited Conditions
  • 9.7. Global Hereditary Genetic Testing Market, Sub-Segmentation Of Prenatal and Newborn Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Non-Invasive Prenatal Testing (NIPT), Amniocentesis and Chorionic Villus Sampling (CVS), Newborn Screening For Genetic Disorders, Preconception Genetic Screening
  • 9.8. Global Hereditary Genetic Testing Market, Sub-Segmentation Of Diagnostic Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Genetic Testing For Confirming Suspected Genetic Disorders, Testing For Inherited Syndromes And Congenital Diseases, Diagnostic Testing For Cancer And Tumor Profiling
  • 9.9. Global Hereditary Genetic Testing Market, Sub-Segmentation Of Pharmacogenomic Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Genetic Testing For Drug Response And Efficacy, Testing For Drug Sensitivities And Side Effects, Personalized Medicine And Treatment Optimization
  • 9.10. Global Hereditary Genetic Testing Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Genetic Testing For Wellness And Lifestyle, Genetic Testing For Ancestry And Genealogy, Research-Oriented Genetic Testing

10. Hereditary Genetic Testing Market Regional And Country Analysis

  • 10.1. Global Hereditary Genetic Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Hereditary Genetic Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Hereditary Genetic Testing Market

  • 11.1. Asia-Pacific Hereditary Genetic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Hereditary Genetic Testing Market, Segmentation By Type, Segmentation By Technology, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Hereditary Genetic Testing Market

  • 12.1. China Hereditary Genetic Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Hereditary Genetic Testing Market, Segmentation By Type, Segmentation By Technology, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Hereditary Genetic Testing Market

  • 13.1. India Hereditary Genetic Testing Market, Segmentation By Type, Segmentation By Technology, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Hereditary Genetic Testing Market

  • 14.1. Japan Hereditary Genetic Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Hereditary Genetic Testing Market, Segmentation By Type, Segmentation By Technology, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Hereditary Genetic Testing Market

  • 15.1. Australia Hereditary Genetic Testing Market, Segmentation By Type, Segmentation By Technology, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Hereditary Genetic Testing Market

  • 16.1. Indonesia Hereditary Genetic Testing Market, Segmentation By Type, Segmentation By Technology, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Hereditary Genetic Testing Market

  • 17.1. South Korea Hereditary Genetic Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Hereditary Genetic Testing Market, Segmentation By Type, Segmentation By Technology, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Hereditary Genetic Testing Market

  • 18.1. Taiwan Hereditary Genetic Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Hereditary Genetic Testing Market, Segmentation By Type, Segmentation By Technology, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Hereditary Genetic Testing Market

  • 19.1. South East Asia Hereditary Genetic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Hereditary Genetic Testing Market, Segmentation By Type, Segmentation By Technology, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Hereditary Genetic Testing Market

  • 20.1. Western Europe Hereditary Genetic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Hereditary Genetic Testing Market, Segmentation By Type, Segmentation By Technology, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Hereditary Genetic Testing Market

  • 21.1. UK Hereditary Genetic Testing Market, Segmentation By Type, Segmentation By Technology, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Hereditary Genetic Testing Market

  • 22.1. Germany Hereditary Genetic Testing Market, Segmentation By Type, Segmentation By Technology, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Hereditary Genetic Testing Market

  • 23.1. France Hereditary Genetic Testing Market, Segmentation By Type, Segmentation By Technology, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Hereditary Genetic Testing Market

  • 24.1. Italy Hereditary Genetic Testing Market, Segmentation By Type, Segmentation By Technology, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Hereditary Genetic Testing Market

  • 25.1. Spain Hereditary Genetic Testing Market, Segmentation By Type, Segmentation By Technology, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Hereditary Genetic Testing Market

  • 26.1. Eastern Europe Hereditary Genetic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Hereditary Genetic Testing Market, Segmentation By Type, Segmentation By Technology, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Hereditary Genetic Testing Market

  • 27.1. Russia Hereditary Genetic Testing Market, Segmentation By Type, Segmentation By Technology, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Hereditary Genetic Testing Market

  • 28.1. North America Hereditary Genetic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Hereditary Genetic Testing Market, Segmentation By Type, Segmentation By Technology, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Hereditary Genetic Testing Market

  • 29.1. USA Hereditary Genetic Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Hereditary Genetic Testing Market, Segmentation By Type, Segmentation By Technology, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Hereditary Genetic Testing Market

  • 30.1. Canada Hereditary Genetic Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Hereditary Genetic Testing Market, Segmentation By Type, Segmentation By Technology, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Hereditary Genetic Testing Market

  • 31.1. South America Hereditary Genetic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Hereditary Genetic Testing Market, Segmentation By Type, Segmentation By Technology, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Hereditary Genetic Testing Market

  • 32.1. Brazil Hereditary Genetic Testing Market, Segmentation By Type, Segmentation By Technology, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Hereditary Genetic Testing Market

  • 33.1. Middle East Hereditary Genetic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Hereditary Genetic Testing Market, Segmentation By Type, Segmentation By Technology, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Hereditary Genetic Testing Market

  • 34.1. Africa Hereditary Genetic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Hereditary Genetic Testing Market, Segmentation By Type, Segmentation By Technology, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Hereditary Genetic Testing Market Regulatory and Investment Landscape

36. Hereditary Genetic Testing Market Competitive Landscape And Company Profiles

  • 36.1. Hereditary Genetic Testing Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Hereditary Genetic Testing Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Hereditary Genetic Testing Market Company Profiles
    • 36.3.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis

37. Hereditary Genetic Testing Market Other Major And Innovative Companies

  • Hologic Inc., Exact Sciences Corporation, Fulgent Genetics Inc., BioReference Laboratories Inc., BGI Group, Invitae Corporation, Color Health Inc., MedGenome Inc., Devyser AB, Mapmygenome India Ltd., Igenomix S.L.P., Myriad Genetics Inc., Natera Inc., Ambry Genetics Corporation, GeneDx LLC

38. Global Hereditary Genetic Testing Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Hereditary Genetic Testing Market

40. Hereditary Genetic Testing Market High Potential Countries, Segments and Strategies

  • 40.1 Hereditary Genetic Testing Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Hereditary Genetic Testing Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Hereditary Genetic Testing Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer